Elevation Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-65
Closed -$4.63K 1324
2026
Q1
$4.63K Buy
65
+36
+124% +$2.84K ﹤0.01% 733
2025
Q4
$2.38K Sell
29
-20
-41% -$1.56K ﹤0.01% 767
2025
Q3
$3.68K Buy
49
+41
+513% +$3.06K ﹤0.01% 531
2025
Q2
$593 Hold
8
﹤0.01% 450
2025
Q1
$646 Sell
8
-4
-33% -$344 ﹤0.01% 452
2024
Q4
$939 Hold
12
﹤0.01% 451
2024
Q3
$1.13K Sell
12
-12
-50% -$1.01K ﹤0.01% 433
2024
Q2
$1.87K Buy
24
+4
+20% +$326 ﹤0.01% 451
2024
Q1
$1.82K Hold
20
﹤0.01% 420
2023
Q4
$1.36K Hold
20
﹤0.01% 403
2023
Q3
$1.36K Hold
20
﹤0.01% 301
2023
Q2
$1.63K Hold
20
﹤0.01% 310
2023
Q1
$1.64K Buy
+20
New +$1.43K ﹤0.01% 312

Other funds holding GEHC

Elevation Wealth Partners's GEHC Position: Q2 2026 in Review

Elevation Wealth Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 65 shares — an estimated $4.63K sold.

Elevation Wealth Partners first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $4.63K in Q1 2026. 443 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Elevation Wealth Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Elevation Wealth Partners sold 65 GE HealthCare shares in Q2 2026, an estimated $4.63K.
  • Elevation Wealth Partners first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Elevation Wealth Partners's GE HealthCare position peaked at $4.63K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.